| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
|
Cox, Maria Christina
|
|
|
86 |
6 |
p. 841-846
|
artikel
|
| 2 |
Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
|
Hata, Kojiro
|
|
|
86 |
6 |
p. 803-813
|
artikel
|
| 3 |
Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal®) in glioma patients in China
|
Hu, Chaoying
|
|
|
86 |
6 |
p. 793-801
|
artikel
|
| 4 |
Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients
|
Hansen, Mads Kingo Guldberg
|
|
|
86 |
6 |
p. 751-759
|
artikel
|
| 5 |
Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma
|
Ni, Xiang-Rong
|
|
|
86 |
6 |
p. 773-782
|
artikel
|
| 6 |
Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
|
Zhang, Zhen
|
|
|
86 |
6 |
p. 761-772
|
artikel
|
| 7 |
Mass balance, metabolic disposition, and pharmacokinetics of [14C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration
|
Zhou, Sufeng
|
|
|
86 |
6 |
p. 719-730
|
artikel
|
| 8 |
Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal function
|
Yu, Yanke
|
|
|
86 |
6 |
p. 701-710
|
artikel
|
| 9 |
Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation
|
Bhoopalan, Senthil Velan
|
|
|
86 |
6 |
p. 711-717
|
artikel
|
| 10 |
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
|
Do, Khanh T.
|
|
|
86 |
6 |
p. 815-827
|
artikel
|
| 11 |
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)
|
Greengard, Emily
|
|
|
86 |
6 |
p. 829-840
|
artikel
|
| 12 |
The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo
|
Zhong, Tangwu
|
|
|
86 |
6 |
p. 783-792
|
artikel
|
| 13 |
The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis
|
Ye, Chen
|
|
|
86 |
6 |
p. 731-740
|
artikel
|
| 14 |
Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors
|
Latoch, Eryk
|
|
|
86 |
6 |
p. 741-749
|
artikel
|
Tijdschrift beschrijving